Eligibility Expanded for Second Dose COVID-19 Vaccination in Lambton County

Residents in Lambton County aged 75 and older, or those who received their first dose of a COVID-19 vaccine on or before March 31, are now eligible to book their second dose vaccination appointments. This expansion in eligibility follows the recent update from the National Advisory Committee on Immunization (NACI) and the Province of Ontario regarding the interchangeability of COVID-19 vaccines for second doses. Individuals who received a first dose of the AstraZeneca vaccine within the same time period may also choose to book a second dose appointment for another approved COVID-19 mRNA vaccine, such as Pfizer or Moderna.

Key Takeaways:

  • Individuals aged 75 and older, or those who received their first dose of a COVID-19 vaccine on or before March 31, are eligible to book their second dose vaccination appointments.
  • Those who received a first dose of the AstraZeneca vaccine within the same time period may choose to book a second dose appointment for another approved COVID-19 mRNA vaccine (i.e., Pfizer or Moderna).
  • NACI recommends that individuals who received the AstraZeneca vaccine for their first dose should receive either the same vaccine or an mRNA vaccine (Pfizer-BioNTech or Moderna) for their second dose.
  • Lambton Public Health will continue to prioritize individuals who are medically eligible for a reduced second dose, High-Risk Healthcare workers, and Indigenous individuals to book their second dose appointments.
  • Residents will be notified of their eligibility to book directly via email or phone, with broader communications made via weekly news releases, website, and social media channels.

Statistics:

  • 75 and older individuals and those who received their first dose of a COVID-19 vaccine on or before March 31 are eligible to book their second dose vaccination appointments.
  • Individuals who received a first dose of the AstraZeneca vaccine within the same time period may choose to book a second dose appointment for another approved COVID-19 mRNA vaccine.
  • NACI recommends interchangeability of COVID-19 vaccines for second doses based on studies from Germany, the UK, and Spain.

Sources:

  • Lambton Public Health
  • National Advisory Committee on Immunization (NACI)
  • Province of Ontario
  • Germany
  • UK
  • Spain